Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424–5p/suppressor of zeste 12 pathway

Jia Liu,Hongqin Zhao,Qian Zhang,Zhengzheng Shi,Yuyang Zhang,Liang Zhao,Yi Ren,Rongying Ou,Yunsheng Xu
DOI: https://doi.org/10.1016/j.yexcr.2020.112277
IF: 4.145
2020-11-01
Experimental Cell Research
Abstract:<p>Human papillomavirus (HPV) infection and viral protein expression cause several epigenetic alterations that lead to cervical carcinogenesis. Our previous study identified that upregulated lysine-specific demethylase (KDM) 2 A promotes cervical cancer progression by inhibiting mircoRNA (miR)-132 function. However, the roles of histone methylation modifiers in HPV-related cervical cancer remain unclear. In the present study, changes in the expression of 48 histone methylation modifiers were assessed following knockdown of HPV16 E6/E7 in CaSki cells. The dysregulated expression of KDM5A was identified, and its function in cervical cancer was investigated <em>in vitro</em> and <em>in vivo</em>. E7 oncoprotein-induced upregulation of KDM5A promoted cervical cancer cell proliferation and invasiveness <em>in vitro</em> and <em>in vivo</em>, which was correlated with poor prognosis in patients with cervical cancer. KDM5A was found to physically interact with the promoter region of miR-424–5p, and to suppress its expression by removing the tri- and di-methyl groups from H3K4 at the miR-424–5p locus. Furthermore, miR-424–5p repressed cancer cell proliferation and invasiveness by targeting suppressor of zeste 12 (Suz12). KDM5A upregulation promoted cervical cancer progression by repressing miR-424–5p, which resulted in a decrease in Suz12. Therefore, KDM5A functions as a tumor activator in cervical cancer pathogenesis by binding to the miR-424–5p promoter and inhibiting its tumor-suppressive function. These results indicate a function for KDM5A in cervical cancer progression and suggest its candidacy as a novel prognostic biomarker and target for the clinical management of this malignancy.</p>
oncology,cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how human papillomavirus type 16 (HPV16) E7 oncoprotein promotes the progression of cervical cancer by up - regulating lysine - specific demethylase 5A (KDM5A), and the specific mechanism is through regulating microRNA - 424 - 5p (miR - 424 - 5p) and suppressor of zeste 12 (Suz12) pathways. The study aims to reveal the role of KDM5A in the occurrence and development of cervical cancer and its potential as a prognostic biomarker and a treatment target. ### Research Background - **Cervical Cancer**: It is the third most common malignant tumor among women worldwide, with approximately 528,000 new cases every year. HPV infection, especially HPV16 and HPV18, is considered as the main cause of cervical cancer. - **Epigenetic Changes**: Multiple epigenetic changes occur during HPV infection and the process of cervical cancer transformation, among which histone lysine methylation is a key modification process. - **KDM5A**: KDM5A is a histone demethylase that can remove trimethyl and dimethyl groups on H3K4 and affect gene expression. ### Research Purposes - **Explore the Role of E7 Oncoprotein**: Study how the E7 oncoprotein up - regulates the expression of KDM5A and how this up - regulation promotes the development of cervical cancer. - **Reveal miR - 424 - 5p and Suz12 Pathways**: Explore how KDM5A affects the expression of Suz12 by inhibiting the expression of miR - 424 - 5p, thereby promoting the proliferation and invasiveness of cervical cancer cells. - **Evaluate the Clinical Significance of KDM5A**: Analyze the expression level of KDM5A in cervical cancer patients and its relationship with prognosis, and evaluate its potential as a prognostic biomarker and a treatment target. ### Main Findings - **Up - regulation of KDM5A**: The E7 oncoprotein significantly up - regulates the expression of KDM5A, and the expression level of KDM5A in cervical cancer tissues is higher than that in normal tissues. - **Function of KDM5A**: KDM5A directly binds to and inhibits the promoter region of miR - 424 - 5p by removing trimethyl and dimethyl groups on H3K4, resulting in a decrease in the expression of miR - 424 - 5p. - **Role of miR - 424 - 5p**: miR - 424 - 5p inhibits the proliferation and invasiveness of cervical cancer cells by targeting Suz12. - **Relationship between KDM5A and Suz12**: KDM5A indirectly up - regulates the expression of Suz12 by inhibiting the expression of miR - 424 - 5p, thereby promoting the development of cervical cancer. ### Conclusion KDM5A plays an important role in the occurrence and development of cervical cancer. By inhibiting the expression of miR - 424 - 5p and up - regulating the expression of Suz12, it promotes the proliferation and invasiveness of cervical cancer cells. These results suggest that KDM5A may be a potential prognostic biomarker and treatment target, which is helpful for the clinical management of cervical cancer.